Skip to content

PipelineTM Flex Embolization Device with Shield TechnologyTM PED2-300-25Recalls & reported problems

Micro Therapeutics, Inc. · STENT PED2-300-25 V06 E-IFU · Class 3 · Implant

All models of PipelineTM Flex Embolization Device with Shield TechnologyTM (79)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
3
Deaths reported
1
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 00763000284015), received between Jan 10, 2022 and Nov 6, 2025 — classified as 1 death, 2 malfunctions.

The most frequently reported specific device problem is “Activation Failure” (2 reports).

12 other recalls cover devices cleared under the same FDA submission (P100018); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 1 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 1 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Activation Failure2
  • Adverse Event Without Identified Device or Use Problem1
  • Material Deformation1

Patient problems

  • No Clinical Signs, Symptoms or Conditions2
  • Obstruction/Occlusion1
  • Rupture1

Recent adverse event reports

The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.

  • MalfunctionNov 6, 2025Material Deformation; Activation Failure; Material Deformation; Activation Failure

    ADDITIONAL INFORMATION WAS RECEIVED. THE CAUSE OF THE FAILURE TO OPEN WAS ATTRIBUTED TO THE OPENING AT THE TIP OF THE STENT BEING TAPERED COMPARED TO THE DIAMETER OF THE STENT, WITH INCONSISTENT DIAMETERS AT THE FRONT AND BACK. TIP DAMAGE WAS LIKELY CAUSED BY THE TIP END NOT FULLY OPENING AND BECOMING ROUGH DUE TO REPEATED ENTRY AND EXIT FROM THE STENT CATHETER DURING MULTIPLE PUSH-PULL DEPLOYMENT ATTEMPTS. THE SECTION OF THE PIPELINE THAT DID NOT OPEN WAS THE TIP/DISTAL END, AND IT HAD NOT BEEN PLACED IN A VESSEL BEND AT THE TIME OF FAILURE. NO ADDITIONAL STEPS OR DEVICES WERE USED TO OPEN THE PIPELINE. THE OBSERVED TIP END DAMAGE WAS DESCRIBED AS ROUGH, RATHER THAN A BREAK OR KINK. NO RESISTANCE WAS ENCOUNTERED IN ANY SECTION OF THE CATHETER, A CONTINUOUS SALINE FLUSH WAS MAINTAINED AS INDICATED IN THE IFU, AND NO DAMAGE WAS OBSERVED TO THE PIPELINE PUSHWIRE OR CATHETER.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 23490616 ↗
  • MalfunctionAug 22, 2025Activation Failure; Activation Failure

    MEDTRONIC RECEIVED INFORMATION REGARDING A PIPELINE SHIELD THAT FAILED TO OPEN AND HAD FISHMOUTH DEFORMATION AT THE DISTAL END. THE PATIENT WAS UNDERGOING A PROCEDURE FOR FLOW DIVERSION TREATMENT OF LEFT INTERNAL CAROTID ARTERY (L-ICA) TANDEM UNRUPTURED AMORPHOUS ANEURYSMS. ANEURYSMS HAD MAX DIAMETER OF 3.34MM AND 3.25MM AND NECK DIAMETERS OF 3.12MM AND 2.52MM RESPECTIVELY. VESSEL TORTUOSITY WAS MODERATE. DUAL ANTIPLATELET TREATMENT (DAPT) WAS ADMINISTERED. IT WAS REPORTED THAT THE PIPELINE AND ALL ACCESSORY DEVICES WERE PREPARED AS INDICATED IN THE INSTRUCTIONS FOR USE (IFU). THE MICROC ATHETER WAS ADVANCED OVER A 0.14 GUIDEWIRE TO THE RIGHT MIDDLE CEREBRAL ARTERY (MCA) M2 SEGMENT AND THE GUIDEWIRE WAS WITHDRAWN. AFTER HYDRATION, THE PIPELINE SHIELD WAS ADVANCED TO GO UPPER VIA THE PHENOM 27 MICROCATHETER. THE MICROCATHETER WAS WITHDRAWN, INITIATING PIPELINE DEPLOYMENT IN THE M1 STRAIGHT SEGMENT. HOWEVER, THE PIPELINE STENT DID NOT OPEN. IT WAS DEPLOYED FURTHER BUT THE TIP STILL DID NOT OPEN. THE PIPELINE WAS RETRIEVED AND DEPLOYED AGAIN BUT THE FAILURE WAS STILL NOT RESOLVED. THE INTERMEDIATE CATHETER WAS PUSHED TO GO UPPER AND TO TRY AND DEPLOY THE PIPELINE SUFFICIENTLY, THE SYS

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 22874444 ↗
  • DeathJan 10, 2022Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    MEDTRONIC RECEIVED INFORMATION THAT TWO PIPELINE FLEX SHIELDS WERE USED WITHOUT ISSUE AND FOLLOW UP IMAGING CONFIRMED EXCELLENT PLACEMENT AND APPOSITION. AS THE SYSTEM WAS REMOVED AFTER DEPLOYMENT IT APPEARED THAT THE STRESS ON THE VESSEL CAUSED THE VESSEL TO RE-RUPTURE. AFTER THE ANEURYSM RUPTURED THE ENTIRE RIGHT SIDE OF THE ANTERIOR CIRCULATION SHUT DOWN. THE PATIENT IS DECEASED. THE PATIENT WAS BEING TREATED FOR A RUPTURED FUSIFORM ANEURYSM IN THE RIGHT A2 LOCATION. THE MAX DIAMETER WAS 2MM AND THE NECK DIAMETER WAS 20MM. THE DISTAL LANDING ZONE WAS 2.6MM AND THE PROXIMAL LANDING ZONE WAS 2.8MM. VESSEL TORTUOSITY WAS MINIMAL. THE PIPELINE WAS USED FOR A INDICATION THAT WAS NOT APPROVED: A2. THE DEVICES WERE PREPARED ACCORDING TO THE INSTRUCTION FOR USE (IFU). ANGIOGRAPHIC RESULT POST PROCEDURE; BOTH ACA AND MCA WERE COMPLETELY CLOTTED.

    Patient problems: Obstruction/Occlusion; Rupture

    MAUDE report 13215310 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under P100018. One submission often covers many models, so check the product and lot details in each record.

  • Z-1245-2025 · Jan 30, 2025 · Open, Classified
    Medtronic Pipeline Vantage Embolization Device with Shield Technology, REF: PED3-027-350-12, PED3-027-350-14, PED3-027-350-16, PED3-027-350-20, PED3-027-350-25, PED3-027-400-12, PE
  • Z-1246-2025 · Jan 30, 2025 · Open, Classified
    Medtronic Pipeline Vantage Embolization Device with Shield Technology, REF: PED3-021-350-16, PED3-021-250-14, PED3-021-350-20, PED3-021-250-20, PED3-021-300-16, PED3-021-300-20, PE
  • Z-2402-2021 · Jul 13, 2021 · Open, Classified
    Pipeline Flex Embolization Device
  • Z-2403-2021 · Jul 13, 2021 · Open, Classified
    EV3 Pipeline Flex Embolization Device with Flex Shield Technology
  • Z-1527-2020 · Feb 14, 2020 · Terminated
    ev3 Pipeline Flex Embolization Device. For neurological endovascular use.
  • Z-0307-2017 · Oct 5, 2016 · Terminated
    Pipeline Embolization Device (Pipeline Classic) The device is indicated for the endovascular treatment of adults (22 year of age or older) with large or giant widenecked intracrani
  • Z-0309-2017 · Oct 5, 2016 · Terminated
    Marathon Flow Directed Micro Catheter, UltraFlow HPC Flow Directed Micro Catheter Marathon Flow: The device is intended to access periphera and neurovasculature for the controlled
  • Z-0308-2017 · Oct 5, 2016 · Terminated
    Alligator Retrieval Device The device is intended for use in the peripheral and neurovasculature for foreign body removal. Catalog No. FA-88810-20V04 FA-88810-20V06 FA-88810-30V04
  • Z-0310-2017 · Oct 5, 2016 · Terminated
    X-Celerator Hydrophilic Exchange Guidewire Catalog No. 103-0601-300 103-0601-350V10 103-0602-350V06 103-0601-300V01 103-0602-300 103-0602-350V09 103-0601-300V02 103-0602-300V01 10
  • Z-0120-2016 · Sep 4, 2015 · Terminated
    -Pipeline Embolization Device -Pipeline Flex Embolization Device The Pipeline and Pipeline Flex Embolization Devices consist of a permanent implant combined with a guidewire based
  • Z-1453-2014 · Apr 1, 2014 · Terminated
    Pipeline Embolization Device (PED). Used endovascular treatment of adults with intracranial aneurysms in the internal carotid artery.
  • Z-2045-2013 · Jul 19, 2013 · Terminated
    Pipeline Embolization Device (PED) The Pipeline Embolization Device is indicated for the endovascular treatment of adults (22 years of age and older) with large or giant wide-neck

Other Intracranial aneurysm flow diverter devices

All Intracranial aneurysm flow diverter devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page